Treatment of alcoholism using psychedelic drugs: a review of the program of research

This review (1998) looks at the history of LSD as a possible treatment for alcoholism (AUD). It highlights the research that had been done and how psychedelics were subsequently relabelled as drugs of abuse.

Abstract of Treatment of alcoholism using psychedelic drugs

“Following Albert Hofmann‘s discovery of LSD’s psychoactive properties in 1943, and previous to their scheduling as controlled substances, the psychedelic drugs were widely studied – six international conferences and hundreds of papers discussed their potential therapeutic usefulness. The observation that the frightening experience of delirium tremens sometimes led alcoholics to moderate their alcohol intake suggested to early psychedelic researchers that the “psychotomimetic” experience thought to be produced by LSD could be used to treat alcoholism. A number of hypothesis-generating studies employing a variety of research designs to examine this premise were completed, but relatively few controlled trials attempted hypothesis testing. After twenty-five years of study, a combination of flawed methodology, uneven results and social reprehension led to the abandonment of research on the therapeutic use of psychedelic drugs, leaving many avenues of inquiry unexplored and many questions unanswered. Today, after a thirty-year hiatus, this research is gradually being resumed, and there is renewed interest in the findings of previous studies. This article explores the history of one branch of psychedelic research, the therapeutic use of LSD in the treatment of alcoholism, and of the events that led to the relabeling of the “hallucinogens” as drugs of abuse.” 

Author: Mariavittoria Mangini

Summary of Treatment of alcoholism using psychedelic drugs

Smith’s report described a pilot study of LSD and mescaline treatment of “particularly refractory alcoholics”, who had been diagnosed with character disorder, psychopathy, borderline or actual psychoses, and concomitant use of drugs other than alco­hol.

Smith addressed the importance of follow-up in estimating the effectiveness of new treatment, and noted that patients can relapse after being helped by the treatment.

Smith’s follow-up report on the pilot study reiterated his original conclusion that the results were encouraging enough to warrant more extensive and controlled trials.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Treatment of alcoholism using psychedelic drugs: a review of the program of research

https://doi.org/10.1080/02791072.1998.10399714

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Mangini, M. (1998). Treatment of alcoholism using psychedelic drugs: a review of the program of research. Journal of psychoactive drugs30(4), 381-418.

Study details

Compounds studied
LSD

Topics studied
Addiction Alcohol Use Disorder

Study characteristics
Literature Review

PDF of Treatment of alcoholism using psychedelic drugs: a review of the program of research